ArticleIndian journal of psychological medicine2025
Exploring the Perceived Acceptability of a Proposed Mobile Application Designed to Improve Medication Adherence Among People with Schizophrenia and Their Caregivers.
Article in Indian journal of psychological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Multiple challenges, including limited technical knowledge, privacy concerns, or financial constraints to afford a smartphone, limit the introduction and implementation of a mobile application-based intervention aimed at supporting medication adherence for people with schizophrenia (SZ) in a low-resource setting. Recognising these barriers, this study aimed to explore the perceived acceptability of a mobile application specifically designed to improve medication adherence among individuals with SZ and their caregivers (CG). Methods: A total of 64 individuals diagnosed with SZ, who had been in remission for the past six months, and 36 CG, attending the outpatient psychiatry department of a tertiary care teaching institution, were recruited based on predefined selection criteria. The SZ and CG participants were interviewed separately using an adapted version of the Treatment Acceptability and Preference Scale (TAPS), which assessed their perceptions of the appropriateness, suitability, effectiveness, and willingness to use a mobile application. TAPS was administered immediately after describing the proposed features and potential utility of the mobile application designed to improve medication adherence. Results: There were no significant differences in demographic characteristics between SZ and CG, except that CG were significantly more likely to be employed than individuals with SZ ( Conclusion: The mobile application was generally acceptable to patients and CG, with younger and more educated participants showing higher acceptability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.